PMID- 20145209 OWN - NLM STAT- MEDLINE DCOM- 20100427 LR - 20230815 IS - 1937-9145 (Electronic) IS - 1945-0877 (Linking) VI - 3 IP - 108 DP - 2010 Feb 9 TI - ARD1 stabilization of TSC2 suppresses tumorigenesis through the mTOR signaling pathway. PG - ra9 LID - 10.1126/scisignal.2000590 [doi] AB - Mammalian target of rapamycin (mTOR) regulates various cellular functions, including tumorigenesis, and is inhibited by the tuberous sclerosis 1 (TSC1)-TSC2 complex. Here, we demonstrate that arrest-defective protein 1 (ARD1) physically interacts with, acetylates, and stabilizes TSC2, thereby repressing mTOR activity. The inhibition of mTOR by ARD1 inhibits cell proliferation and increases autophagy, thereby inhibiting tumorigenicity. Correlation between ARD1 and TSC2 abundance was apparent in multiple tumor types. Moreover, evaluation of loss of heterozygosity at Xq28 revealed allelic loss in 31% of tested breast cancer cell lines and tumor samples. Together, our findings suggest that ARD1 functions as an inhibitor of the mTOR pathway and that dysregulation of the ARD1-TSC2-mTOR axis may contribute to cancer development. FAU - Kuo, Hsu-Ping AU - Kuo HP AD - 1Department of Molecular and Cellular Oncology, Unit 108, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. FAU - Lee, Dung-Fang AU - Lee DF FAU - Chen, Chun-Te AU - Chen CT FAU - Liu, Mo AU - Liu M FAU - Chou, Chao-Kai AU - Chou CK FAU - Lee, Hong-Jen AU - Lee HJ FAU - Du, Yi AU - Du Y FAU - Xie, Xiaoming AU - Xie X FAU - Wei, Yongkun AU - Wei Y FAU - Xia, Weiya AU - Xia W FAU - Weihua, Zhang AU - Weihua Z FAU - Yang, Jer-Yen AU - Yang JY FAU - Yen, Chia-Jui AU - Yen CJ FAU - Huang, Tzu-Hsuan AU - Huang TH FAU - Tan, Minjia AU - Tan M FAU - Xing, Gang AU - Xing G FAU - Zhao, Yingming AU - Zhao Y FAU - Lin, Chien-Hsing AU - Lin CH FAU - Tsai, Shih-Feng AU - Tsai SF FAU - Fidler, Isaiah J AU - Fidler IJ FAU - Hung, Mien-Chie AU - Hung MC LA - eng GR - P50 CA83639/CA/NCI NIH HHS/United States GR - R01 CA109311/CA/NCI NIH HHS/United States GR - P30 CA016672/CA/NCI NIH HHS/United States GR - P30 CA016672-34S5/CA/NCI NIH HHS/United States GR - CCSG CA16672/CA/NCI NIH HHS/United States GR - CA16672/CA/NCI NIH HHS/United States GR - P50 CA116199/CA/NCI NIH HHS/United States GR - P50 CA083639/CA/NCI NIH HHS/United States GR - R01 CA109311-06/CA/NCI NIH HHS/United States GR - P50 CA083639-100009/CA/NCI NIH HHS/United States GR - P50 CA116199-050005/CA/NCI NIH HHS/United States GR - P01 CA099031-01/CA/NCI NIH HHS/United States GR - P01 CA099031/CA/NCI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, Non-P.H.S. DEP - 20100209 PL - United States TA - Sci Signal JT - Science signaling JID - 101465400 RN - 0 (RNA, Small Interfering) RN - 0 (TSC2 protein, human) RN - 0 (Tsc2 protein, mouse) RN - 0 (Tuberous Sclerosis Complex 2 Protein) RN - 0 (Tumor Suppressor Proteins) RN - EC 2.3.1.- (Acetyltransferases) RN - EC 2.3.1.254 (N-Terminal Acetyltransferase A) RN - EC 2.3.1.255 (NAA10 protein, human) RN - EC 2.3.1.258 (N-Terminal Acetyltransferase E) SB - IM MH - Acetyltransferases/*metabolism MH - Alleles MH - Animals MH - Autophagy MH - Breast Neoplasms/genetics/metabolism MH - Cell Line, Tumor MH - Cell Proliferation MH - *Gene Expression Profiling MH - *Gene Expression Regulation, Neoplastic MH - Heterozygote MH - Humans MH - Mice MH - N-Terminal Acetyltransferase A MH - N-Terminal Acetyltransferase E MH - RNA, Small Interfering/metabolism MH - *Signal Transduction MH - Tuberous Sclerosis Complex 2 Protein MH - Tumor Suppressor Proteins/*metabolism PMC - PMC2874891 MID - NIHMS198006 EDAT- 2010/02/11 06:00 MHDA- 2010/04/28 06:00 PMCR- 2010/05/24 CRDT- 2010/02/11 06:00 PHST- 2010/02/11 06:00 [entrez] PHST- 2010/02/11 06:00 [pubmed] PHST- 2010/04/28 06:00 [medline] PHST- 2010/05/24 00:00 [pmc-release] AID - 3/108/ra9 [pii] AID - 10.1126/scisignal.2000590 [doi] PST - epublish SO - Sci Signal. 2010 Feb 9;3(108):ra9. doi: 10.1126/scisignal.2000590.